Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis
| Status: | Terminated |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/8/2019 |
| Start Date: | May 29, 2018 |
| End Date: | February 4, 2019 |
Comparison of the Healing of Chemotherapy-Induced Oral Mucositis Using Oral Defense Toothpaste Versus Crest Toothpaste and Magic Mouth Rinse
The purpose of this study is to determine whether Oral Defense Toothpaste causes accelerated
healing of chemotherapy-induced oral mucositis.
healing of chemotherapy-induced oral mucositis.
A pilot study showed that patients with chemotherapy-induced oral mucositis experienced
accelerated healing of their oral mucositis by brushing with Oral Defense Toothpaste.
In this study, participants experiencing up to grade 2 chemotherapy-induced oral mucositis
will be split into two arms. The first arm (test arm) will receive Oral Defense Toothpaste
and be required to brush three times per day, for 8 days. The second arm (control arm) will
receive Crest Toothpaste and be required to brush three times per day, for 8 days. Patients
in the control arm will be provided Magic Mouth Rinse, if needed. Healing of oral mucositis
lesions will be evaluated at days 1 and 8. Quality of life assessment (determination of
pain/loss of oral function) will be determined using a daily questionnaire.
accelerated healing of their oral mucositis by brushing with Oral Defense Toothpaste.
In this study, participants experiencing up to grade 2 chemotherapy-induced oral mucositis
will be split into two arms. The first arm (test arm) will receive Oral Defense Toothpaste
and be required to brush three times per day, for 8 days. The second arm (control arm) will
receive Crest Toothpaste and be required to brush three times per day, for 8 days. Patients
in the control arm will be provided Magic Mouth Rinse, if needed. Healing of oral mucositis
lesions will be evaluated at days 1 and 8. Quality of life assessment (determination of
pain/loss of oral function) will be determined using a daily questionnaire.
Inclusion Criteria:
- Patients over the age of 18 receiving chemotherapy
- Mucositis lesions not exceeding grade 2
Exclusion Criteria:
- Patients receiving high load chemotherapy
- Patients receiving radiation therapy
- Patients receiving oral antivirals, oral antifungals or oral antibacterials
- Patients experiencing oral candidiasis
We found this trial at
1
site
Click here to add this to my saved trials
